Prophylactic endoluminal vacuum therapy after major gastrointestinal surgery: a systematic review.


Journal

Updates in surgery
ISSN: 2038-3312
Titre abrégé: Updates Surg
Pays: Italy
ID NLM: 101539818

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 14 01 2022
accepted: 27 02 2022
pubmed: 10 3 2022
medline: 3 8 2022
entrez: 9 3 2022
Statut: ppublish

Résumé

In the last decade, endoluminal vacuum therapy (eVAC) has emerged as an effective treatment for anastomotic leak (AL); however, little is known regarding its prophylactic use. In this systematic review we evaluated overall outcomes in patients undergoing major gastrointestinal surgery and treated with prophylactic eVAC. A systematic review of English articles on four electronic databases was performed according to the PRISMA statement up until January 2022. References of selected articles were manually screened to identify relevant missing papers. Primary endpoints were AL and mortality rates estimates. Secondary endpoints included analysis of eVAC-associated morbidity, treatment duration, long-term complications, and general indications for the eVAC management in the perioperative period. A total of 11 studies (5 case reports, 5 retrospective case series and a retrospective, case-control study) were included in the analysis. AL ranged from 0 to 25%. No major eVAC-associated complications were observed, except for sponge dislocation or obstruction. Overall mortality ranged between 0 and 12.5%; however, these fatalities were neither related to the use of eVAC, nor to AL-associated complications. The most frequent long-term complication was anastomotic stenosis responsive to endoscopic dilatation in most cases. The operating negative pressure ranged from -25 to -125 mmHg among different papers. In all studies but two, prophylactic eVAC was applied to anastomoses at high risk of dehiscence based on the subjective evaluation of the leading surgeon. In conclusion, prophylactic eVAC is safe and it could lead to potential benefit for prevention of AL, especially in high-risk anastomoses.

Identifiants

pubmed: 35262844
doi: 10.1007/s13304-022-01265-x
pii: 10.1007/s13304-022-01265-x
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1177-1186

Informations de copyright

© 2022. Italian Society of Surgery (SIC).

Références

Duan X, Bai W, Ma Z, Yue J, Shang X, Jiang H et al (2020) Management and outcomes of anastomotic leakage after McKeown esophagectomy: a retrospective analysis of 749 consecutive patients with esophageal cancer. Surg Oncol 34:304–309
doi: 10.1016/j.suronc.2020.06.002
Makuuchi R, Irino T, Tanizawa Y, Bando E, Kawamura T, Terashima M (2019) Esophagojejunal anastomotic leakage following gastrectomy for gastric cancer. Surg Today 49(3):187–196. https://doi.org/10.1007/s00595-018-1726-8
doi: 10.1007/s00595-018-1726-8 pubmed: 30317492
Kawaida H, Kono H, Hosomura N, Amemiya H, Itakura J, Fujii H et al (2019) Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery. World J Gastroenterol 25(28):3722–3737
doi: 10.3748/wjg.v25.i28.3722
Foppa C, Ng SC, Montorsi M, Spinelli A (2020) Anastomotic leak in colorectal cancer patients: New insights and perspectives. Eur J Surg Oncol 46(6):943–954
doi: 10.1016/j.ejso.2020.02.027
Vetter D, Gutschow CA (2020) Strategies to prevent anastomotic leakage after esophagectomy and gastric conduit reconstruction. Langenbeck’s Arch Surg 405(8):1069–1077
doi: 10.1007/s00423-020-01926-8
Meyer J, Naiken S, Christou N, Liot E, Toso C, Buchs NC et al (2019) Reducing anastomotic leak in colorectal surgery: the old dogmas and the new challenges. World J Gastroenterol 25(34):5017–5025
doi: 10.3748/wjg.v25.i34.5017
Schoellhammer HF, Fong Y, Gagandeep S (2014) Techniques for prevention of pancreatic leak after pancreatectomy. Hepatobiliary Surg Nutr 3(5):276–287
pubmed: 25392839 pmcid: 4207840
Abdalla S, Cotte E, Epin A, Karoui M, Lefevre JH, Berger A et al (2020) Short-term and long-term outcome of endoluminal vacuum therapy for colorectal or coloanal anastomotic leakage: results of a Nationwide Multicenter Cohort Study From the French GRECCAR Group. Dis Colon Rectum 63(3):371–380
doi: 10.1097/DCR.0000000000001560
Tavares G, Tustumi F, Tristão LS, Bernardo WM (2021) Endoscopic vacuum therapy for anastomotic leak in esophagectomy and total gastrectomy: a systematic review and meta-analysis. Dis Esophagus 34(5):doaa132
doi: 10.1093/dote/doaa132
Chiarello MM, Fransvea P, Cariati M, Adams NJ, Bianchi V, Brisinda G (2022) Anastomotic leakage in colorectal cancer surgery. Surg Oncol 40:101708
doi: 10.1016/j.suronc.2022.101708
Agarwal P, Kukrele R, Sharma D (2019) Vacuum assisted closure (VAC)/negative pressure wound therapy (NPWT) for difficult wounds: a review. J Clin Orthop trauma 10(5):845–848
doi: 10.1016/j.jcot.2019.06.015
Livingstone I, Pollock L, Sgromo B, Mastoridis S (2021) Current Status of Endoscopic Vacuum Therapy in the Management of Esophageal Perforations and Post-Operative Leaks. Clin Endosc. 54(6):787–797
doi: 10.5946/ce.2021.240
Dhindsa BS, Naga Y, Saghir SM, Daid SGS, Chandan S, Mashiana H et al (2021) Endo-sponge in management of anastomotic colorectal leaks: a systematic review and meta-analysis. Endosc Int open 9(9):E1342–E1349
doi: 10.1055/a-1490-8783
Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336–341
doi: 10.1016/j.ijsu.2010.02.007
Loske G, Schorsch T, Schmidt-Seithe H, Müller C (2014) Intraluminal endoscopic vacuum therapy in a case of ischemia of the blind end of the jejunal loop after Roux-en-Y gastrectomy. Endoscopy 46(Suppl 1):E575–E576
pubmed: 25415175
Neumann P-A, Mennigen R, Palmes D, Senninger N, Vowinkel T, Laukoetter MG (2017) Pre-emptive endoscopic vacuum therapy for treatment of anastomotic ischemia after esophageal resections. Endoscopy 49(5):498–503
doi: 10.1055/s-0042-123188
Loske G, Schorsch T, Müller CT (2017) First Report of Intraluminal Endoscopic Negative Pressure Therapy ( ENPT ) for anastomotic prophylaxis in a case of tubular resection of cervical esophagus. Clin Surg 2:1500
Schmidt HM, Vetter D, Gubler C, Valli P, Morell B, Raptis DA et al (2018) PS02.250: Preemptive endoscopic vacuum drainage to prevent anastomotic leakage in upper-GI surgery: a game-changing technology? Dis Esophagus 31(Supplement 1):194. https://doi.org/10.1093/dote/doy089.PS02.250
doi: 10.1093/dote/doy089.PS02.250
Kertesz V, Müller RM, Albinni S, Radlspöck W, Gensthaler L, Schima W et al (2019) Prophylactic Endoscopic Vacuum Assisted Therapy (EVAT) as adjuvant treatment in combination with transcervical closure of a high esophagotracheal fistula. Eur Surg 51(Supplement 1):1–107
de Medeiros FS, do Junior ESM, de França RL, de Neto HCM, Santos JM, Júnior EAA et al (2020) Preemptive endoluminal vacuum therapy after pancreaticoduodenectomy: a case report. World J Gastrointest Endosc 12:493–499
doi: 10.4253/wjge.v12.i11.493
Müller PC, Morell B, Vetter D, Raptis DA, Kapp JR, Gubler C et al (2021) Preemptive endoluminal vacuum therapy to reduce morbidity after minimally invasive ivor lewis esophagectomy: including a novel grading system for postoperative endoscopic assessment of GI-anastomoses. Ann Surg 274(5):751–757
doi: 10.1097/SLA.0000000000005125
Yasuda JL, Svetanoff WJ, Staffa SJ, Zendejas B, Hamilton TE, Jennings RW et al (2021) Prophylactic negative vacuum therapy of high-risk esophageal anastomoses in pediatric patients. J Pediatr Surg 56(5):944–950
doi: 10.1016/j.jpedsurg.2020.12.002
Lehwald-Tywuschik NC, Alexander A, Alkhanji N, Flügen G, Fung S, Rehders A et al (2021) The “impossible” rectal anastomosis: a novel use for endoluminal vacuum-assisted therapy. Tech Coloproctol 25(1):125–130
doi: 10.1007/s10151-020-02363-x
Mandarino FV, Barchi A, Biamonte P, Esposito D, Azzolini F, Fanti L, et al. (2022) The prophylactic use of endoscopic vacuum therapy for anastomotic dehiscence after rectal anterior resection: is it feasible for redo surgery? Tech Coloproctol. 2022. https://doi.org/10.1007/s10151-021-02566-w
Loske G, Müller J, Schulze W, Riefel B, Müller CT (2022) Pre-emptive active drainage of reflux (PARD) in Ivor-Lewis oesophagectomy with negative pressure and simultaneous enteral nutrition using a double-lumen open-pore film drain (dOFD). Surg Endosc 36(3):2208–2216
doi: 10.1007/s00464-021-08933-w
Mennigen R, Senninger N, Laukoetter MG (2015) Endoscopic vacuum therapy of esophageal anastomotic leakage. Gastrointest Endosc 82(2):397
doi: 10.1016/j.gie.2015.02.027
Leeds SG, Mencio M, Ontiveros E, Ward MA (2019) Endoluminal vacuum therapy: how i do it. J Gastrointest Surg 23(5):1037–1043
doi: 10.1007/s11605-018-04082-z
Schaheen L, Blackmon SH, Nason KS (2014) Optimal approach to the management of intrathoracic esophageal leak following esophagectomy: a systematic review. Am J Surg 208(4):536–543
doi: 10.1016/j.amjsurg.2014.05.011
Yibulayin W, Abulizi S, Lv H, Sun W (2016) Minimally invasive oesophagectomy versus open esophagectomy for resectable esophageal cancer: a meta-analysis. World J Surg Oncol 14(1):304
doi: 10.1186/s12957-016-1062-7
Fuchs HF, Harnsberger CR, Broderick RC, Chang DC, Sandler BJ, Jacobsen GR et al (2017) Mortality after esophagectomy is heavily impacted by center volume: retrospective analysis of the Nationwide Inpatient Sample. Surg Endosc 31(6):2491–2497
doi: 10.1007/s00464-016-5251-9
Müller PC, Vetter D, Kapp JR, Gubler C, Morell B, Raptis DA et al (2021) Pre-emptive endoluminal negative pressure therapy at the anastomotic site in minimally invasive transthoracic esophagectomy (the preSPONGE Trial): study protocol for a Multicenter Randomized Controlled Trial. Int J Surg Protoc 25(1):7–15
doi: 10.29337/ijsp.24

Auteurs

Olga Adamenko (O)

Hirslanden Hospitals, Zürich, Switzerland.

Carlo Ferrari (C)

Hirslanden Hospitals, Zürich, Switzerland. dott.ferraricarlo@gmail.com.
Università degli Studi di Milano, Milano, Italy. dott.ferraricarlo@gmail.com.

Stefan Seewald (S)

Hirslanden Hospitals, Zürich, Switzerland.
GastroZentrum Hirslanden, Zürich, Switzerland.

Jan Schmidt (J)

Hirslanden Hospitals, Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH